Literature DB >> 17559145

Trop-1 are conserved growth stimulatory molecules that mark early stages of tumor progression.

Paola Zanna1, Marco Trerotola, Giovanna Vacca, Veronica Bonasera, Barbara Palombo, Emanuela Guerra, Cosmo Rossi, Rossano Lattanzio, Mauro Piantelli, Saverio Alberti.   

Abstract

BACKGROUND: Trop-1 is a cell-cell adhesion regulatory molecule that is overexpressed by a large fraction of tumors in man.
METHODS: To identify fundamental, conserved functional features of Trop-1 in transformed cells, a search was performed for evolutionarily conserved structure, expression patterns, and function by gene cloning, DNA array and serial analysis of gene expression (SAGE), Northern and Western blotting, flow cytometry, and immunohistochemistry of sequential stages of tumor progression in experimental systems and in man.
RESULTS: TROP1 genes demonstrate conserved structure and promoter regions with parallel expression patterns (high expression in the small intestine and colon; lower expression in prostate, thyroid, salivary glands, breast, kidney, lung, liver, and spleen; very low levels in skin and stomach; no expression in heart, muscle, and brain). Progenitor cells of different tissues were shown to express Trop-1. Hence, the expression and functional role of Trop-1 were analyzed at successive stages of tumor progression in vitro and in vivo. The findings show that Trop-1 is expressed at early stages of tumor development, eg, in dysplastic lesions and immortalized cells, is sufficient to stimulate cell growth of expressing transformed cells, and is required for tumor growth in vivo.
CONCLUSIONS: The findings identify Trop-1 as a novel determinant of cell growth at early stages of tumor development and as a marker of early stages of development in normal tissues and in cancer, making this molecule a candidate for novel diagnostic and therapeutic procedures.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17559145     DOI: 10.1002/cncr.22785

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  10 in total

1.  Trop-2 inhibits prostate cancer cell adhesion to fibronectin through the β1 integrin-RACK1 axis.

Authors:  Marco Trerotola; Jing Li; Saverio Alberti; Lucia R Languino
Journal:  J Cell Physiol       Date:  2012-11       Impact factor: 6.384

2.  Expression of Trop2 cell surface glycoprotein in normal and tumor tissues: potential implications as a cancer therapeutic target.

Authors:  Lara P Stepan; Esther S Trueblood; Kari Hale; John Babcook; Luis Borges; Claire L Sutherland
Journal:  J Histochem Cytochem       Date:  2011-05-06       Impact factor: 2.479

3.  CD133, Trop-2 and alpha2beta1 integrin surface receptors as markers of putative human prostate cancer stem cells.

Authors:  Marco Trerotola; Swati Rathore; Hira Lal Goel; Jing Li; Saverio Alberti; Mauro Piantelli; Dave Adams; Zhong Jiang; Lucia R Languino
Journal:  Am J Transl Res       Date:  2010-03-15       Impact factor: 4.060

4.  Trop-2, Na+/K+ ATPase, CD9, PKCα, cofilin assemble a membrane signaling super-complex that drives colorectal cancer growth and invasion.

Authors:  Marco Trerotola; Saverio Alberti; Emanuela Guerra; Valeria Relli; Martina Ceci; Romina Tripaldi; Pasquale Simeone; Anna Laura Aloisi; Ludovica Pantalone; Rossana La Sorda; Rossano Lattanzio; Andrea Sacchetti; Kristina Havas; Simone Guarnieri; Daniele Vergara; Isabelle Fournier; Michel Salzet; Nicola Tinari; Mauro Piantelli
Journal:  Oncogene       Date:  2022-02-07       Impact factor: 8.756

5.  Epithelial cell adhesion molecule (EpCAM) regulates claudin dynamics and tight junctions.

Authors:  Chuan-Jin Wu; Poonam Mannan; Michael Lu; Mark C Udey
Journal:  J Biol Chem       Date:  2013-03-13       Impact factor: 5.157

6.  Effects of EpCAM overexpression on human breast cancer cell lines.

Authors:  Johanna M Gostner; Dominic Fong; Oliver A Wrulich; Florian Lehne; Marion Zitt; Martin Hermann; Sylvia Krobitsch; Agnieszka Martowicz; Guenther Gastl; Gilbert Spizzo
Journal:  BMC Cancer       Date:  2011-01-31       Impact factor: 4.430

7.  p53, cathepsin D, Bcl-2 are joint prognostic indicators of breast cancer metastatic spreading.

Authors:  Emanuela Guerra; Alessia Cimadamore; Pasquale Simeone; Giovanna Vacca; Rossano Lattanzio; Gerardo Botti; Valentina Gatta; Marco D'Aurora; Barbara Simionati; Mauro Piantelli; Saverio Alberti
Journal:  BMC Cancer       Date:  2016-08-18       Impact factor: 4.430

Review 8.  Pharmacogenetic and pharmacogenomic discovery strategies.

Authors:  Concetta Crisafulli; Petronilla Daniela Romeo; Marco Calabrò; Ludovica Martina Epasto; Saverio Alberti
Journal:  Cancer Drug Resist       Date:  2019-06-19

9.  mTrop1/Epcam knockout mice develop congenital tufting enteropathy through dysregulation of intestinal E-cadherin/β-catenin.

Authors:  Emanuela Guerra; Rossano Lattanzio; Rossana La Sorda; Francesca Dini; Gian Mario Tiboni; Mauro Piantelli; Saverio Alberti
Journal:  PLoS One       Date:  2012-11-28       Impact factor: 3.240

10.  Trop-2 is a determinant of breast cancer survival.

Authors:  Federico Ambrogi; Marco Fornili; Patrizia Boracchi; Marco Trerotola; Valeria Relli; Pasquale Simeone; Rossana La Sorda; Rossano Lattanzio; Patrizia Querzoli; Massimo Pedriali; Mauro Piantelli; Elia Biganzoli; Saverio Alberti
Journal:  PLoS One       Date:  2014-05-13       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.